inovio.com
Open in
urlscan Pro
20.245.221.239
Public Scan
Submitted URL: https://www.flvpn.inovio.com/
Effective URL: https://inovio.com/
Submission: On December 16 via automatic, source certstream-suspicious — Scanned from US
Effective URL: https://inovio.com/
Submission: On December 16 via automatic, source certstream-suspicious — Scanned from US
Form analysis
2 forms found in the DOMGET https://inovio.com/
<form role="search" method="get" class="search-form" action="https://inovio.com/">
<input type="search" value="Search INOVIO" onblur="if(this.value=='') this.value='Search INOVIO';" onfocus="if(this.value=='Search INOVIO') this.value='';" name="s">
<button type="submit" class="search-submit"></button>
</form>
GET https://inovio.com/
<form role="search" method="get" class="search-form" action="https://inovio.com/">
<input type="search" value="Search INOVIO" onblur="if(this.value=='') this.value='Search INOVIO';" onfocus="if(this.value=='Search INOVIO') this.value='';" name="s">
<button type="submit" class="search-submit"></button>
</form>
Text Content
This website is AudioEye enabled and is being optimized for accessibility. To open the AudioEye Toolbar, press "shift + =". Some assistive technologies may require the use of a passthrough function before this keystroke. For more information, activate the button labeled “Explore your accessibility options”. * * * * * * For Patients: Clinical Trials * Publications * Careers * Contact Us Toggle navigation * About INOVIO * Purpose, Mission and Values * Leadership * Partnerships * DNA Medicines Technology * Optimized Plasmid Design and Delivery * DNA Medicines Explained * The Promise of DNA Medicine * NEXT GEN DNA MEDICINE * DNA Medicines Pipeline * Investors & Media * Events & Presentations * Stock Information * News Releases * SEC Filings * Analyst Coverage * Corporate Governance * Shareholder Services * FAQ * For Patients: Clinical Trials * Publications * Careers * Contact Us * * About INOVIO * Purpose, Mission and Values * Leadership * Partnerships * DNA Medicines Technology * Optimized Plasmid Design and Delivery * DNA Medicines Explained * The Promise of DNA Medicine * NEXT GEN DNA MEDICINE * DNA Medicines Pipeline * Investors & Media * Events & Presentations * Stock Information * News Releases * SEC Filings * Analyst Coverage * Corporate Governance * Shareholder Services * FAQ * For Patients: Clinical Trials * Publications * Careers * Contact Us WORKING TO CHANGE TREATMENT PARADIGMS AND IMPROVE LIVES We’re developing innovative, next-generation medicines to fight HPV-related diseases, cancer and infectious diseases. LEARN MORE DRIVING PROGRESS WITH CUTTING-EDGE TECHNOLOGY Our platform features optimized design and delivery of medicines that teach the body to manufacture its own disease-fighting tools. LEARN MORE BUILDING ON THE PROMISE OF DNA MEDICINE A growing body of research indicates that DNA medicines offer many potential advantages and are generally well-tolerated, versatile, immunogenic and scalable. LEARN MORE HARNESSING THE POWER OF IN VIVO PROTEIN PRODUCTION INOVIO is a clinical-stage biotechnology company focused on developing DNA medicines to fight HPV-related diseases, cancer and infectious diseases. We use proprietary technology to design DNA plasmids —small circular DNA molecules that work like software that the body’s cells can download to learn how to produce specific proteins to target and fight disease. Our proprietary investigational CELLECTRA® delivery devices have been designed to optimally deliver our DNA medicines into the body’s cells, without the use of chemical adjuvants, lipid nanoparticles or viral vectors. LATEST INOVIO NEWS December 13, 2024 INOVIO ANNOUNCES PRICING OF $30 MILLION PUBLIC OFFERING (read more) December 12, 2024 INOVIO ANNOUNCES PROPOSED PUBLIC OFFERING (read more) December 3, 2024 NEW RETROSPECTIVE DATA SHOWS HALF OF RRP PATIENTS TREATED WITH INO-3107 ACHIEVED A COMPLETE RESPONSE WHEN EVALUATED 2 AND 3 YEARS FOLLOWING INITIAL PHASE 1/2 TRIAL (read more) PETER KIES CHIEF FINANCIAL OFFICER “DNA medicine has the potential to be transformational for patients around the world. We are dedicated to delivering on that promise.” Learn More MICHAEL SUMNER Chief Medical Officer “Across our pipeline we’re working to advance DNA medicine and develop innovative, next-generation therapies with groundbreaking potential.” Learn More LAURENT HUMEAU, Ph.D. Chief Scientific Officer “Our research is advancing the next generation of DNA medicine technology and driving innovation in how we treat and protect people from disease.” Learn More JACQUELINE SHEA, Ph.D. PRESIDENT & CHIEF EXECUTIVE OFFICER “As we prepare to submit our first BLA, INOVIO stands poised to make DNA medicines a reality for patients and stakeholders. We would not be here today without the strategic vision and innovative drive of our uniquely experienced team.” Learn More PETER KIES CHIEF FINANCIAL OFFICER “DNA medicine has the potential to be transformational for patients around the world. We are dedicated to delivering on that promise.” Learn More MICHAEL SUMNER Chief Medical Officer “Across our pipeline we’re working to advance DNA medicine and develop innovative, next-generation therapies with groundbreaking potential.” Learn More LAURENT HUMEAU, Ph.D. Chief Scientific Officer “Our research is advancing the next generation of DNA medicine technology and driving innovation in how we treat and protect people from disease.” Learn More JACQUELINE SHEA, Ph.D. PRESIDENT & CHIEF EXECUTIVE OFFICER “As we prepare to submit our first BLA, INOVIO stands poised to make DNA medicines a reality for patients and stakeholders. We would not be here today without the strategic vision and innovative drive of our uniquely experienced team.” Learn More SUBSCRIBE FOR UPDATES FROM INOVIO Register to receive email alerts for INOVIO press releases * * * * * * About Inovio * DNA Medicines Technology * DNA Medicines Pipeline * Investors & Media * For Patients * Publications * Careers * Contact Us * Safe Harbor Statement * Expanded Access * Privacy Policy * Terms & Conditions © Copyright 2024 INOVIO Pharmaceuticals. All rights reserved. Opens in new window PDF Download Word Download Excel Download PowerPoint Download Document Download Explore your accessibility options close carousel